45 related articles for article (PubMed ID: 19786339)
1. Symptomatic and functional outcome in youth at ultra-high risk for psychosis: a longitudinal study.
Lemos-Giráldez S; Vallina-Fernández O; Fernández-Iglesias P; Vallejo-Seco G; Fonseca-Pedrero E; Paíno-Piñeiro M; Sierra-Baigrie S; García-Pelayo P; Pedrejón-Molino C; Alonso-Bada S; Gutiérrez-Pérez A; Ortega-Ferrández JA
Schizophr Res; 2009 Dec; 115(2-3):121-9. PubMed ID: 19786339
[TBL] [Abstract][Full Text] [Related]
2. Early prodromal symptoms can predict future psychosis in familial high-risk youth.
Tandon N; Montrose D; Shah J; Rajarethinam RP; Diwadkar VA; Keshavan MS
J Psychiatr Res; 2012 Jan; 46(1):105-10. PubMed ID: 22056319
[TBL] [Abstract][Full Text] [Related]
3. Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort.
Brucato G; Masucci MD; Arndt LY; Ben-David S; Colibazzi T; Corcoran CM; Crumbley AH; Crump FM; Gill KE; Kimhy D; Lister A; Schobel SA; Yang LH; Lieberman JA; Girgis RR
Psychol Med; 2017 Aug; 47(11):1923-1935. PubMed ID: 28249639
[TBL] [Abstract][Full Text] [Related]
4. Prediction of conversion to psychosis: review and future directions.
Gee DG; Cannon TD
Braz J Psychiatry; 2011 Oct; 33 Suppl 2(0 2):s129-42. PubMed ID: 22286564
[TBL] [Abstract][Full Text] [Related]
5. Study protocol for a prospective cohort study examining the predictive potential of dynamic symptom networks for the onset and progression of psychosis: the Mapping Individual Routes of Risk and Resilience (Mirorr) study.
Booij SH; Wichers M; de Jonge P; Sytema S; van Os J; Wunderink L; Wigman JTW
BMJ Open; 2018 Jan; 8(1):e019059. PubMed ID: 29358438
[TBL] [Abstract][Full Text] [Related]
6. Symptom trajectories and psychosis onset in a clinical high-risk cohort: the relevance of subthreshold thought disorder.
DeVylder JE; Muchomba FM; Gill KE; Ben-David S; Walder DJ; Malaspina D; Corcoran CM
Schizophr Res; 2014 Nov; 159(2-3):278-83. PubMed ID: 25242361
[TBL] [Abstract][Full Text] [Related]
7. Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional Domains.
Allswede DM; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan T; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cannon TD
Am J Psychiatry; 2020 Feb; 177(2):164-171. PubMed ID: 31509005
[TBL] [Abstract][Full Text] [Related]
8. RNA-sequencing of peripheral whole blood of individuals at ultra-high-risk for psychosis - A longitudinal perspective.
Tan SMX; Yee JY; Budhraja S; Singh B; Doborjeh Z; Doborjeh M; Kasabov N; Lai E; Sumich A; Lee J; Goh WWB
Asian J Psychiatr; 2023 Nov; 89():103796. PubMed ID: 37837946
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic and Functional Outcomes Among Individuals at High Risk for Psychosis Participating in Step-Based Care.
Hamilton SA; Wastler HM; Moe AM; Cowan HR; Lundin NB; Guirgis HH; Parris CJ; Stearns WH; Manges ME; Holmes AC; Blouin AM; Breitborde NJK
Psychiatr Serv; 2024 May; 75(5):496-499. PubMed ID: 38088038
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal MicroRNA Signature of Conversion to Psychosis.
Iftimovici A; He Q; Jiao C; Duchesnay E; Krebs MO; Kebir O; Chaumette B
Schizophr Bull; 2024 Mar; 50(2):363-373. PubMed ID: 37607340
[TBL] [Abstract][Full Text] [Related]
11. Dynamic endophenotypes and longitudinal trajectories: capturing changing aspects of development in early psychosis.
Shah JL; Chakravarty MM; Joober R; Lepage M
J Psychiatry Neurosci; 2016 Apr; 41(3):148-51. PubMed ID: 27116900
[No Abstract] [Full Text] [Related]
12. Collaborative research for psychosis prediction and prevention.
Kelleher I; Healy C; O'Hare K; Lång U
Early Interv Psychiatry; 2024 Apr; 18(4):284-285. PubMed ID: 38586969
[No Abstract] [Full Text] [Related]
13. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study.
Ruhrmann S; Schultze-Lutter F; Salokangas RK; Heinimaa M; Linszen D; Dingemans P; Birchwood M; Patterson P; Juckel G; Heinz A; Morrison A; Lewis S; von Reventlow HG; Klosterkötter J
Arch Gen Psychiatry; 2010 Mar; 67(3):241-51. PubMed ID: 20194824
[TBL] [Abstract][Full Text] [Related]
14. The heterogeneity of attenuated and brief limited psychotic symptoms: association of contents with age, sex, country, religion, comorbidities, and functioning.
Theisen C; Rosen M; Meisenzahl E; Koutsouleris N; Lichtenstein T; Ruhrmann S; Kambeitz J; Kambeitz-Ilankovic L; Riecher-Rössler A; Chisholm K; Upthegrove R; Antonucci LA; Bertolino A; Pigoni A; Salokangas RKR; Pantelis C; Wood SJ; Lencer R; Falkai P; Hietala J; Brambilla P; Schmidt A; Andreou C; Borgwardt S; Osman N; Schultze-Lutter F
Front Psychiatry; 2023; 14():1209485. PubMed ID: 37484669
[TBL] [Abstract][Full Text] [Related]
15. Review of factors resulting in systemic biases in the screening, assessment, and treatment of individuals at clinical high-risk for psychosis in the United States.
Bridgwater MA; Petti E; Giljen M; Akouri-Shan L; DeLuca JS; Rakhshan Rouhakhtar P; Millar C; Karcher NR; Martin EA; DeVylder J; Anglin D; Williams R; Ellman LM; Mittal VA; Schiffman J
Front Psychiatry; 2023; 14():1117022. PubMed ID: 36993932
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis.
Salazar de Pablo G; Soardo L; Cabras A; Pereira J; Kaur S; Besana F; Arienti V; Coronelli F; Shin JI; Solmi M; Petros N; Carvalho AF; McGuire P; Fusar-Poli P
Epidemiol Psychiatr Sci; 2022 Jan; 31():e9. PubMed ID: 35042573
[TBL] [Abstract][Full Text] [Related]
17. Negative Prognostic Effect of Baseline Antipsychotic Exposure in Clinical High Risk for Psychosis (CHR-P): Is Pre-Test Risk Enrichment the Hidden Culprit?
Raballo A; Poletti M; Preti A
Int J Neuropsychopharmacol; 2021 Sep; 24(9):710-720. PubMed ID: 34036323
[TBL] [Abstract][Full Text] [Related]
18. Effects of age and sex on clinical high-risk for psychosis in the community.
Schultze-Lutter F; Schimmelmann BG; Flückiger R; Michel C
World J Psychiatry; 2020 May; 10(5):101-124. PubMed ID: 32477906
[TBL] [Abstract][Full Text] [Related]
19. Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective.
Sheffield JM; Karcher NR; Barch DM
Neuropsychol Rev; 2018 Dec; 28(4):509-533. PubMed ID: 30343458
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
